Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1697901

registered interest
date	21/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ovarian Cancer: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to reduce regional variations in early diagnosis of ovarian cancer.
tabling member constituency	Slough
tabling member printed	Mr Tanmanjeet Singh Dhesi
uin	19931
answer	answer is ministerial correction date of answer 28/03/2024 answer text <p>Reducing inequalities and variation in cancer treatment is a priority for the Government, as is increasing early cancer diagnosis, as both are key contributors to reducing cancer health inequalities. The National Health Service is improving cancer pathways to get people diagnosed faster once referred, and is looking into alternative routes into the system, including non-specific symptom (NSS) pathways for patients who do not fit clearly into a single urgent cancer referral pathway, but who are at risk of being diagnosed with cancer. This will help support faster ovarian cancer diagnosis. 113 NSS pathways are currently operational, with more in development.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 28/03/2024 11:38:14 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1696676

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the adequacy of (a) funding and (b) support available for research into non-invasive cancer monitoring technologies.
tabling member constituency	Slough
tabling member printed	Mr Tanmanjeet Singh Dhesi
uin	19142
answer	answer is ministerial correction date of answer 26/03/2024 answer text <p>Research is crucial in tackling cancer, which is why the Department invests over £1 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £121.8 million in 2022/23 and the NIHR spends more on cancer than any other disease group.</p><p>In terms of adequacy of funding, the NIHR funds research in response to proposals received from scientists, rather than allocating funding to specific disease areas. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.</p><p> </p><p>Regarding technologies, the NIHR’s Invention for Innovation (i4i) Programme is a translational research funding scheme aimed at supporting medical devices, such as non-invasive cancer monitoring technologies, and includes in vitro diagnostic devices and digital health technologies addressing an existing or emerging health or social care need. Further information is available at the following link:</p><p><a href="https://www.nihr.ac.uk/explore-nihr/funding-programmes/invention-for-innovation.htm" target="_blank">https://www.nihr.ac.uk/explore-nihr/funding-programmes/invention-for-innovation.htm</a></p><p>Additionally, in September 2023, the Office for Life Sciences Cancer Mission launched the £12 million NIHR i4i Cancer Mission: Early Cancer Diagnosis Clinical Validation and Evaluation Call, aiming to support the clinical validation and evaluation of breakthrough technologies that can increase the proportion of cancers that are detected earlier in the disease course and target health inequalities in cancer diagnosis.</p><p>The NIHR continues to welcome and encourage funding applications for research into any aspect of human health, including cancer monitoring technologies, and it is worth noting that all applications that were fundable in open competition, have been funded.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 26/03/2024 12:01:10 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1696677

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health: Technology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help encourage innovation in the development of healthcare technology for at home use.
tabling member constituency	Slough
tabling member printed	Mr Tanmanjeet Singh Dhesi
uin	19143
answer	answer is ministerial correction date of answer 26/03/2024 answer text <p>In February 2023, the Department published the MedTech strategy which outlined how we will work with key stakeholders, including technology developers and academia, to ensure the health and social care system can reliably access safe, effective, and innovative medical technologies. To accelerate the introduction of innovative medical solutions, we are working with stakeholders at pace to implement solutions to streamline and join-up the innovation adoption pathway, from providing clear signals to industry on the innovation we need, to reforming regulation, comparative assessment, and with clearer procurement pathways.</p><p> </p><p>In October 2023, the Government announced £30 million of investment in the Health Tech Adoption and Acceleration Fund. The fund is supporting integrated care systems to invest in the latest technology to help cut waiting lists, speed up diagnosis, and deliver new and improved ways to treat patients. Thanks to this fund, tens of thousands of patients at risk of kidney disease will be able to get tested from the comfort of their own homes. In February 2024, the Government announced eight innovative tech companies who will be supported to bring their devices to market through the Innovative Devices Access Pathway (IDAP). One of the technologies allows chemotherapy patients to self-test at home, using a finger-prick blood test, for neutropenic sepsis. Another is a smartphone app that delivers exercises, cognitive behaviour therapy, and targeted physical activity in a personally customisable format to help patients manage multiple sclerosis.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 19144 question first answered 26/03/2024 11:31:48 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1696679

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health: Technology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the NHS is taking steps with (a) technology developers and (b) academia to help accelerate the introduction of innovative medical solutions.
tabling member constituency	Slough
tabling member printed	Mr Tanmanjeet Singh Dhesi
uin	19144
answer	answer is ministerial correction date of answer 26/03/2024 answer text <p>In February 2023, the Department published the MedTech strategy which outlined how we will work with key stakeholders, including technology developers and academia, to ensure the health and social care system can reliably access safe, effective, and innovative medical technologies. To accelerate the introduction of innovative medical solutions, we are working with stakeholders at pace to implement solutions to streamline and join-up the innovation adoption pathway, from providing clear signals to industry on the innovation we need, to reforming regulation, comparative assessment, and with clearer procurement pathways.</p><p> </p><p>In October 2023, the Government announced £30 million of investment in the Health Tech Adoption and Acceleration Fund. The fund is supporting integrated care systems to invest in the latest technology to help cut waiting lists, speed up diagnosis, and deliver new and improved ways to treat patients. Thanks to this fund, tens of thousands of patients at risk of kidney disease will be able to get tested from the comfort of their own homes. In February 2024, the Government announced eight innovative tech companies who will be supported to bring their devices to market through the Innovative Devices Access Pathway (IDAP). One of the technologies allows chemotherapy patients to self-test at home, using a finger-prick blood test, for neutropenic sepsis. Another is a smartphone app that delivers exercises, cognitive behaviour therapy, and targeted physical activity in a personally customisable format to help patients manage multiple sclerosis.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 19143 question first answered 26/03/2024 11:31:48 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1696681

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential impact of (a) the breast cancer monitoring device and (b) other innovative medical devices on (i) early cancer detection rates and (ii) patient outcomes.
tabling member constituency	Slough
tabling member printed	Mr Tanmanjeet Singh Dhesi
uin	19145
answer	answer is ministerial correction date of answer 26/03/2024 answer text <p>The Department has not yet assessed the potential impact of breast cancer monitoring devices. This technology is at an early stage and further evidence is needed before we can assess whether it could be trialled in medical settings.</p><p>Improving the early diagnosis of cancer, including breast cancers, is a priority for the National Health Service. NHS England has an ambition to diagnose 75% of cancers at stage one or two by 2028, which will help tens of thousands of people live for longer. NHS England is working to meet the Faster Diagnosis Standard (FDS) which sets a target of 28 days from urgent referral by a general practitioner or screening programme, to patients being told that they have cancer, or that cancer is ruled out.</p><p>In January 2022 the Department provided £10 million of funding for 28 new breast screening units and nearly 60 life-saving upgrades to services in the areas where they are most needed, so more women can be checked for signs of cancer, speeding up diagnosis and treatment.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 19146 question first answered 26/03/2024 11:35:55 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1696682

registered interest
date	18/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of breast cancer monitoring devices on global health outcomes.
tabling member constituency	Slough
tabling member printed	Mr Tanmanjeet Singh Dhesi
uin	19146
answer	answer is ministerial correction date of answer 26/03/2024 answer text <p>The Department has not yet assessed the potential impact of breast cancer monitoring devices. This technology is at an early stage and further evidence is needed before we can assess whether it could be trialled in medical settings.</p><p>Improving the early diagnosis of cancer, including breast cancers, is a priority for the National Health Service. NHS England has an ambition to diagnose 75% of cancers at stage one or two by 2028, which will help tens of thousands of people live for longer. NHS England is working to meet the Faster Diagnosis Standard (FDS) which sets a target of 28 days from urgent referral by a general practitioner or screening programme, to patients being told that they have cancer, or that cancer is ruled out.</p><p>In January 2022 the Department provided £10 million of funding for 28 new breast screening units and nearly 60 life-saving upgrades to services in the areas where they are most needed, so more women can be checked for signs of cancer, speeding up diagnosis and treatment.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 19145 question first answered 26/03/2024 11:35:55 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1696280

registered interest
date	14/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Waiting Lists
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to support hospital trusts with significant waiting lists to (a) share and (b) implement best practices in (i) England and (ii) Slough constituency.
tabling member constituency	Slough
tabling member printed	Mr Tanmanjeet Singh Dhesi
uin	18767
answer	answer is ministerial correction date of answer 20/03/2024 answer text <p>The National Health Service and the Department are aiming to transform elective care across England. This includes providing additional regional or national support and intervention to the most challenged trusts. We are driving activity by using wider system capacity, through use of the independent sector, mutual aid, offering patients a choice at the point of referral, and expanding and protecting elective planned diagnostic services through community diagnostic centres (CDC). In January 2024, a new CDC opened in Slough delivering additional checks, tests, and scans as mobile activity. To help manage the demand, the NHS is providing ongoing rigorous delivery monitoring, sharing best practice approaches between trusts, providing specialised advice in primary care, and driving productivity through pilot schemes and a new network of surgical hubs.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/03/2024 15:30:36 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1694538

registered interest
date	07/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Waiting Lists
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of NHS funding to tackle the backlog of (a) elective surgeries and (b) other non-emergency procedures.
tabling member constituency	Slough
tabling member printed	Mr Tanmanjeet Singh Dhesi
uin	17645
answer	answer is ministerial correction date of answer 14/03/2024 answer text <p>The Government is committed to making the best possible progress against the ambitions set out in the Elective Recovery Plan (ERP), despite a range of constraints that have impacted on delivery. These constraints have included, but were not limited to, higher than expected COVID-19 and non-COVID-19 related bed occupancy, and periods of disruptive industrial action.</p><p>The Government regularly reviews progress against the ambitions in the ERP, including affordability, and the impact of the constraints listed above. The Government is planning to spend more than £8 billion from 2022/23 to 2024/25, to help drive up and protect elective activity.</p><p>This is supported by NHS England’s planning guidance, which in 2023/24 set an initial elective recovery target of 107%, delivered through a payment-by-result mechanism. To reflect the impact of industrial action, the Government and NHS England agreed to revise the elective activity target to 103% for the remainder of 2023/24, and in November 2023 provided an additional £800 million of funding from a combination of reprioritised and new funding, to mitigate the costs of industrial action. Planning guidance for 2024/25 will set out the ambitions for 2024/25, and will be published shortly.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/03/2024 14:08:13 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1694539

registered interest
date	07/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Comment entitled Health spending planned to fall in England and Scotland in 2024–25, suggesting a top-up likely, published by the Institute for Fiscal Studies on 4 March 2024, what steps he is taking to help ensure the NHS maintains (a) quality of care and (b) patient outcomes in the 2024/25 financial year.
tabling member constituency	Slough
tabling member printed	Mr Tanmanjeet Singh Dhesi
uin	17646
answer	answer is ministerial correction date of answer 18/03/2024 answer text <p>The Spring Budget 2024 announced that the Government is protecting the day-to-day funding of the National Health Service in England, providing an extra £2.45 billion in 2024/25. This will allow the NHS to continue to focus on reducing waiting times, and will bring the NHS’s resource budget in 2024/25 to £164.9 billion. This means that NHS funding will increase from 2023/24, and equates to a real terms increase of 13% since 2019/20.</p><p>An additional £3.4 billion of capital funding announced at the budget will aid the NHS’ technological and digital transformation over three years, between 2025/26 and 2027/28. This will provide wider benefits to quality of care and patient outcomes, such as better prevention, and patients living longer and healthier lives, as a result of receiving scans earlier. Devolved administrations, including Scotland, will benefit from additional funding through the Barnett formula.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 18/03/2024 10:09:59 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1692800

registered interest
date	29/02/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ovarian Cancer: Health Education
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she is taking steps to increase awareness of ovarian cancer symptoms.
tabling member constituency	Slough
tabling member printed	Mr Tanmanjeet Singh Dhesi
uin	16431
answer	answer is ministerial correction date of answer 06/03/2024 answer text <p>NHS England is taking a wide range of activity to increase awareness and early diagnosis of, as well as tackle regional variations in, ovarian cancer. Since 2020 NHS England has run several Help Us Help You campaigns, that have included a focus on abdominal symptoms which, amongst other abdominal cancers, can be indicative of ovarian cancer.</p><p> </p><p>NHS England relaunched the Help Us Help You cancer campaign on the 8 January 2024, to encourage people to get in touch with their general practitioner if they notice, or are worried about, symptoms that could be cancer. The campaign address barriers to people coming forward with suspected signs of cancer in general, and is not specific to ovarian cancer.</p><p> </p><p>Raising awareness and improving early diagnosis of cancers, including ovarian cancer, remains a priority across all regions in England. NHS England is working towards the NHS Long Term Plan ambition of diagnosing 75% of stageable cancers at stage one and two by 2028. Achieving this will mean that, from 2028, around 55,000 more people each year will survive their cancer for at least five years after diagnosis.</p><p> </p><p>To help increase cancer diagnosis rates, as of February 2024, there are 154 community diagnostic centres (CDCs) open with over six million checks carried out, with the aim of having 160 CDCs open by March 2025. We also plan to transform the way the National Health Service provides elective care, by increasing activity at dedicated and protected surgical hubs. These will help separate elective care facilities from urgent and emergency care, including for ovarian cancer. At present, the surgical hubs are focusing on a number of specialities, including gynaecology.</p><p> </p><p>The NHS is improving pathways to get people diagnosed faster once they are referred, and is looking into alternative routes into the system, including non-specific symptom (NSS) pathways for patients who do not fit clearly into a single urgent cancer referral pathway, but who are at risk of being diagnosed with cancer. This will help support faster ovarian cancer diagnosis. 108 NSS pathways are currently operational, with more in development.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 16432 16433 question first answered 06/03/2024 12:33:46 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi